Literature DB >> 35339459

Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.

Saumya Kasliwal1, Seyda Baydogan1, Devon Harrison2, Maureen Mork3, Anirban Maitra4, Florencia Mcallister5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35339459      PMCID： PMC9245458          DOI： 10.1053/j.gastro.2022.03.026

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  8 in total

1.  Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.

Authors:  Michael J Pishvaian; Edik M Blais; Jonathan R Brody; Emily Lyons; Patricia DeArbeloa; Andrew Hendifar; Sam Mikhail; Vincent Chung; Vaibhav Sahai; Davendra P S Sohal; Sara Bellakbira; Dzung Thach; Lola Rahib; Subha Madhavan; Lynn M Matrisian; Emanuel F Petricoin
Journal:  Lancet Oncol       Date:  2020-03-02       Impact factor: 41.316

2.  The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy.

Authors:  Vasily Giannakeas; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2017-09-15       Impact factor: 4.872

3.  Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities.

Authors:  Michael S Lee; Shubham Pant
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

4.  Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.

Authors:  Chunling Hu; Steven N Hart; Eric C Polley; Rohan Gnanaolivu; Hermela Shimelis; Kun Y Lee; Jenna Lilyquist; Jie Na; Raymond Moore; Samuel O Antwi; William R Bamlet; Kari G Chaffee; John DiCarlo; Zhong Wu; Raed Samara; Pashtoon M Kasi; Robert R McWilliams; Gloria M Petersen; Fergus J Couch
Journal:  JAMA       Date:  2018-06-19       Impact factor: 56.272

5.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

Authors:  Mary B Daly; Robert Pilarski; Matthew B Yurgelun; Michael P Berry; Saundra S Buys; Patricia Dickson; Susan M Domchek; Ahmed Elkhanany; Susan Friedman; Judy E Garber; Michael Goggins; Mollie L Hutton; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison W Kurian; Christine Laronga; Jennifer K Litton; Julie S Mak; Carolyn S Menendez; Sofia D Merajver; Barbara S Norquist; Kenneth Offit; Tuya Pal; Holly J Pederson; Gwen Reiser; Kristen Mahoney Shannon; Kala Visvanathan; Jeffrey N Weitzel; Myra J Wick; Kari B Wisinski; Mary A Dwyer; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2020-04       Impact factor: 11.908

6.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.

Authors:  Koji Shindo; Jun Yu; Masaya Suenaga; Shahriar Fesharakizadeh; Christy Cho; Anne Macgregor-Das; Abdulrehman Siddiqui; P Dane Witmer; Koji Tamura; Tae Jun Song; Jose Alejandro Navarro Almario; Aaron Brant; Michael Borges; Madeline Ford; Thomas Barkley; Jin He; Matthew J Weiss; Christopher L Wolfgang; Nicholas J Roberts; Ralph H Hruban; Alison P Klein; Michael Goggins
Journal:  J Clin Oncol       Date:  2017-08-02       Impact factor: 44.544

7.  Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.

Authors:  Anu Chittenden; Sigurdis Haraldsdottir; Chinedu Ukaegbu; Meghan Underhill-Blazey; Shraddha Gaonkar; Hajime Uno; Lauren K Brais; Kimberly Perez; Brian M Wolpin; Sapna Syngal; Matthew B Yurgelun
Journal:  JCO Oncol Pract       Date:  2021-01-13

8.  The new 'normal': Rapid adoption of telemedicine in orthopaedics during the COVID-19 pandemic.

Authors:  Andrew M Rizzi; William S Polachek; Matthew Dulas; Jason A Strelzow; Kelly K Hynes
Journal:  Injury       Date:  2020-09-16       Impact factor: 2.586
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.